Characteristics of Successful International Pharmacy Partnerships
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Participants
2.3. Data Collection
2.4. Data Analysis
3. Results
“I know (the collaborator). There is a personal, level of trust, and we can get something done. I know MOUs are good to get institutional support. But, if we don’t have an inside person that we can deal with, the MOU becomes not useful.”
“When you sign an MOU, the partners need to agree to what would be the benefits in a partnership…I was lucky…those people that approached us, they knew upfront what they could contribute in terms of research, collaboration, a teaching collaboration, and so our biggest benefit was this.”
“I really look at relationships I have when I’m at different conferences, and we look to see whether or not there are any similarities within our institutions or where we can work together. And that’s where I start from.”
“There are differences in practice, which I think being a preceptor, we need to help the students understand this and how to manage certain issues so that, at the end of the day, it will be a win-win situation.”
“Yeah, I think what is most complicated for us, more difficult for us to understand is how the US education system works. Like, you enter the university system, and then you take all these different classes and subjects and then you master or take your degree. I don’t know at some point you decide you want to, how do you say that, you want to major at some point. I don’t know”
“Institutional memory has been kept because the champions remained constant. Other people may think differently. And you remember also cultural exchange rates. You develop bonds, personal bonds, you know cultural bonds. Those are taken for granted, because you know, sometimes when there’s no funding the push to look for funding, this is coming from inside personally, because you have not developed your bond with the support group or with children by one part of the world, and so forth.”
“Partnerships definitely help strengthen our voice when it comes to health care within the country.”
“Joint publications. You and I published a paper together, or write a book chapter together. And then collaborate [with] students together. That is more than enough. And then, if we are released into the research, we can write a grant. Joint grant writing, and we can submit… Okay, otherwise we are jointly training students, so we might as well jointly develop curriculum.”
“So there has to be trust instead of a document [i.e., MOU]…Once you have a good partner, that is willing to work on things.”
“I had two students from (institution), they helped me put together the pharmacy program here. They used their knowledge of pharmacy and my knowledge, and then the government pharmacist knowledge… If it wasn’t for that, there would be a massive shortage of pharmacists… right now.”
“I wish that going forward when we have a critical mass of mentors that understand global health, what international exchanges is all about. We will do all the technical, but we must know that we are dealing with a holistic situation…and a cultural exchange aspect.”
“I think our biggest expectation is that they should be willing to learn new things because …working in a low to middle income country you might have all the knowledge, you might know the best way to treat a patient, but that medicine, all that treatment is not available in the country so how do you juggle that. So in that instance, that you must be willing to listen, learn how we do things, and it’s not necessarily that it’s the best way to do things but it’s the only way we have and we have to make that work. We discussed this earlier, you know, is to be culturally sensitive because we dealing also with this issue of colonialism. And you know as an academic bringing in US students I get confronted at management level about colonialism…They need to be sensitive towards that and not get offended……It’s trying to give them that opportunity to give a plan of how they would treat this patient in the US, but then to bring the context to them the challenges that we face with access to medicine and then develop a new plan and that willingness to learn and change becomes important.”
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Item No. | Guide Question/Description | Page No. | |
---|---|---|---|
Domain 1: Research Team and Reflexivity | |||
Interviewer/Facilitator | 1 | Which author/s conducted the interview or focus group? GP, SS, LJ, JA, LH, MKS | Methods-4 |
Credentials | 2 | What were the researchers’ credentials? PharmD Student (KT/NF) | Title Page |
Occupation | 3 | What was their occupation at the time of the study? Faculty Student (KT/NF) | Title Page |
Gender | 4 | Was the researcher male or female? Both were represented | |
Experience and Training | 5 | What experience or training did the researcher have? All interviewers had qualitative research experience | Methods-4 |
Domain 1: Relationship with participants | |||
Relationship Established | 6 | Was a relationship established prior to the study commencement? Yes, to varying degrees | Methods-3 |
Participant Knowledge of the Interviewer | 7 | What did the participants know about the researcher?, e.g., personal goals, reasons for doing the research?Upon contact, collaborators were made aware of the study purpose and that investigators were members of the GOC. Informed consent was sent to review via email. | Methods-3 |
Interviewer Characteristics | 8 | What characteristics were reported about the interviewer/facilitator? Faculty, GOC member | Methods-4 |
Domain 2: Study Design | |||
Methodological Orientations/Theory | 9 | What methodological orientation was stated to underpin the study? Content Analysis | Methods-4 |
Sampling | 10 | How were the participants selected? Purposive | Methods-4 |
Method of Approach | 11 | How were the participants approached? | Methods-3 |
Sample Size | 12 | How many participants were approached? 17 approached; 14 different sites interviewed | Results-4 |
Non-participation | 13 | How many people refused to participate or dropped out? 3 did not respond | Results-4 |
Setting of Data Collection | 14 | Where was the data collected? Workplace, Zoom | Methods-4 |
Presence of Non-participants | 15 | Was anyone else present besides the participants and researchers? No | Methods-4 |
Description of Sample | 16 | What are the important characteristics of the sample? All participants were engaged in global health collaborations in their county Interviews were conducted between November 2021–June 2022 | Methods-4 |
Interview Guide | 17 | Were questions, prompts, guides provided by the authors? Was it pilot tested? Interview Questions were used; Pre-testing was performed with one international partners | Methods-2 Table 1 |
Repeat Interviews | 18 | Were repeat interviews carried out? No | |
Audio/Visual Recording | 19 | Did the research use audio and visual recording to collect the data? All interviews were recorded and transcribed | Methods-4 |
Field Notes | 20 | Were field notes made during and/or/after the interview or the focus group? Yes, one researcher served as a scribe | Methods-4 |
Duration | 21 | What was the duration of the interviews or focus groups? 1 h | Methods-4 |
Data Saturation | 22 | Was data saturation discussed? Yes, continued until enough participations | Methods-4 |
Transcripts Returned | 23 | Were transcripts returned for comments or correction? | |
Domain 3: Analysis and Findings | |||
Number of Data Coders | 24 | How many data coders coded the data? Two for each interviewer | Methods-4 |
Description of the Coding Tree | 25 | Did authors provide a description of the coding tree? A code book was developed | Methods-4 |
Derivation of Themes | 26 | Were themes identified in advance or derived from the data? Yes, immersion-crystallization | Methods-4 Table 2 |
Software | 27 | What software, if applicable, was used to manage data? None | Methods-4 |
Participant Checking | 28 | Did participants provide feedback on the findings? No | |
Reporting | |||
Quotations Presented | 29 | Were participant quotations presented to illustrate the themes/findings? Yes | Results-7, 8, 9 |
Data and Findings Consistent | 30 | Was there consistency between the data presented and the findings? Yes | Results |
Clarity of Major Themes | 31 | Were major themes clearly presented in the findings? Yes | Table 2 Results |
Clarity of Minor Themes | 32 | Is there a description of diverse cases or discussion of minor themes? No |
References
- Alsharif, N.Z.; Dakkuri, A.; Abrons, J.P.; Williams, D.; Ombengi, D.N.; Zheng, H.; Al-Dahir, S.; Tofade, T.; Gim, S.; O’Connell, M.B.; et al. Current Practices in Global/International Advanced Pharmacy Practice Experiences: Home/Host Country or Site/Institution Considerations. Am. J. Pharm. Educ. 2016, 80, 38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Prescott, G.M.; Vu, B.N.; Alsharif, N.Z.; Prescott, W.A., Jr. Global Health Education in Doctor of Pharmacy Programs in the United States. Am. J. Pharm. Educ. 2017, 81, 28. [Google Scholar] [CrossRef]
- Crowe, S.J.; Karwa, R.; Schellhase, E.M.; Miller, M.L.; Abrons, J.P.; Alsharif, N.Z.; Andrade, C.; Cope, R.J.; Dornblaser, E.K.; Hachey, D.; et al. American College of Clinical Pharmacy Global Health Practice and Research Network’s opinion paper: Pillars for global health engagement and key engagement strategies for pharmacists. J. Am. Coll. Clin. Pharm. 2020, 3, 1–16. [Google Scholar] [CrossRef]
- Dornblaser, E.K.; Ratka, A.; Gleason, S.E.; Ombengi, D.N.; Tofade, T.; Wigle, P.R.; Zapantis, A.; Ryan, M.; Connor, S.; Jonkman, L.J.; et al. Current Practices in Global/International Advanced Pharmacy Practice Experiences: Preceptor and Student Considerations. Am. J. Pharm. Educ. 2016, 80, 39. [Google Scholar] [CrossRef] [Green Version]
- Johnson, K.L.; Alsharif, N.Z.; Rovers, J.; Connor, S.; White, N.D.; Hogue, M.D. Recommendations for Planning and Managing International Short-term Pharmacy Service Trips. Am. J. Pharm. Educ. 2017, 81, 81223. [Google Scholar] [CrossRef] [PubMed]
- Wietholter, J.P.; Coetzee, R.; Nardella, B.; Slain, D. Facilitating International Healthcare Experiences, 2nd ed.; IGI Global: Hershey, PA, USA, 2020; Volume 1, pp. 111–142. [Google Scholar] [CrossRef]
- Wietholter, J.P.; Coetzee, R.; McCartney, J.; Gegg, J.; Schwinghammer, T.L. Development of an international advanced pharmacy practice experience (APPE) and lessons learned after implementation. Curr. Pharm. Teach. Learn. 2014, 6, 304–312. [Google Scholar] [CrossRef]
- Tong, A.; Sainsbury, P.; Craig, J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 2007, 19, 349–357. [Google Scholar] [CrossRef] [Green Version]
- Violette, R.R.; Houle, S.K.D.; Nissen, L.M.; Waite, N.M. The International Pharmacists-as-Immunizers Partnership (IPIP)—Advancing Research on Pharmacist-Administered Immunizations Worldwide. Pharmacy 2019, 7, 53. [Google Scholar] [CrossRef] [Green Version]
- Micallef, R.; Kayyali, R. Interviews with Global Pharmacists and Healthcare Professionals in Great Britain to Establish Personal Experiences around Professional Development Activity. Pharmacy 2022, 10, 7. [Google Scholar] [CrossRef]
- Haltom, W.R.; Dinkins, M.M.; Greene, J.; Thornhill, T.H.; Brown, K.P.D. Perceived value of partnerships between schools of pharmacy and health systems. Curr. Pharm. Teach. Learn. 2019, 11, 541–546. [Google Scholar] [CrossRef]
- Mickan, S.; Hoffman, S.J.; Nasmith, L.; on behalf of the World Health Organization Study Group on Interprofessional Education and Collaborative Practice. Collaborative practice in a global health context: Common themes from developed and developing countries. J. Interprofessional Care 2010, 24, 492–502. [Google Scholar] [CrossRef] [PubMed]
- Bress, A.P.; Filtz, M.R.; Truong, H.-A.; Nalder, M.; Vienet, M.; Boyle, C.J. An advanced pharmacy practice experience in Melbourne, Australia: Practical guidance for global experiences. Curr. Pharm. Teach. Learn. 2011, 3, 53–62. [Google Scholar] [CrossRef]
- Maponga, C.C.; Monera-Penduka, T.G.; Mtisi, T.J.; Difrancesco, R.; Makita-Chingombe, F.; Mazambara, F.; Tooley, K.; Mudzviti, T.; Morse, G.D. Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained setting. Cost Eff. Resour. Alloc. 2021, 19, 1–8. [Google Scholar] [CrossRef]
- Zhou, D.T.; Maponga, C.C.; Madhombiro, M.; Dube, A.; Mano, R.; Nyamhunga, A.; Machingura, I.; Manasa, J.; Hakim, J.; Chirenje, Z.M.; et al. Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effort. J. Public Heal. Afr. 2019, 10, 1081. [Google Scholar] [CrossRef] [Green Version]
- Karwa, R.; Miller, M.L.; Schellhase, E.; Tran, D.; Manji, I.; Njuguna, B.; Fletcher, S.; Kanyi, J.; Maina, M.; Jakait, B.; et al. Evaluating the impact of a 15-year academic partnership to promote sustainable engagement, education, and scholarship in global health. J. Am. Coll. Clin. Pharm. 2020, 3, 885–896. [Google Scholar] [CrossRef]
- Goff, D.A.; Bauer, K.A.; Brink, A.; Kolman, S.; Mendelson, M.; Messina, A.P.; Schellack, N.; Bergh, D. International Train the Trainer antibiotic stewardship program for pharmacists: Implementation, sustainability, and outcomes. JACCP J. Am. Coll. Clin. Pharm. 2020, 3, 869–876. [Google Scholar] [CrossRef]
- Nathisuwan, S.; Pattharachayakul, S.; Subongkot, S.; Doungngern, T.; Jones, S.M.; Engle, J.P.; Lau, A.; Katz, M.D.; Moreton, J.E.; Ryan, M.U.S. Thai Consortium for the development of pharmacy education in Thailand: History, progress, and impact. Int. J. Avian Wildl. Biol. 2020, 3, 935–946. [Google Scholar] [CrossRef]
- Wu, C.; Lin, F.; Lin, S.; Ho, Y.; Huang, C.; Shen, L.; Wu, F.L. Clinical pharmacy service and international collaboration: Model and experience from a medical center in Taiwan. JACCP J. Am. Coll. Clin. Pharm. 2020, 3, 959–965. [Google Scholar] [CrossRef]
- Cheng, K.-J.; Kuo, L.-N.; Shen, W.-C.; Chen, H.-Y.; Chien, S.-C.; Chen, B.-L.; Chang, E.H. Development of a specialist pharmacist career ladder system and a pharmacy residency program as a result of global partnerships: The experience of Taipei Medical University. J. Am. Coll. Clin. Pharm. 2020, 3, 897–904. [Google Scholar] [CrossRef]
- Hovland, K. Global learning: Defining, designing, demonstrating. American Association of Colleges and Universities. 2014. Available online: https://goglobal.fiu.edu/_assets/docs/hovland-2014_global_learning-defining-designing-demonstrating_2014-1.pdf (accessed on 18 November 2022).
- FIP Academic Pharmacy Section. The FIP Global Competency Framework for Educators & Trainers in Pharmacy (FIP-GCFE). 2022. Available online: https://www.fip.org/file/5235 (accessed on 18 November 2022).
- Saperstein, E. Post-pandemic citizenship: The next phase of global citizenship education. PROSPECTS 2022, 1–15. [Google Scholar] [CrossRef]
- Jogerst, K.; Callender, B.; Adams, V.; Evert, J.; Fields, E.; Hall, T.; Olsen, J.; Rowthorn, V.; Rudy, S.; Shen, J.; et al. Identifying Interprofessional Global Health Competencies for 21st-Century Health Professionals. Ann. Glob. Heal. 2015, 81, 239–247. [Google Scholar] [CrossRef] [PubMed]
- Global Health Competencies Toolkit. Consortium of Universities for Global Health, 2nd ed. Available online: https://www.cugh.org/online-tools/competencies-toolkit/. (accessed on 10 October 2022).
- Matsumoto, D.; Hwang, H.C. Assessing Cross-Cultural Competence. J. Cross Cult. Psychol. 2013, 44, 849–873. [Google Scholar] [CrossRef] [Green Version]
- Fitzgerald, E.A.; Marzalik, P.R.; Kue, J. Assessing Intercultural Development Pre- and Post Education Abroad. J. Nurs. Educ. 2018, 57, 747–750. [Google Scholar] [CrossRef] [PubMed]
- Medina, M.S.; Maerten-Rivera, J.; Zhao, Y.; Henson, B. A Systematic Review of Assessment Tools Measuring Cultural Competence Outcomes Relevant to Pharmacy Education. Am. J. Pharm. Educ. 2022, 86, 8672. [Google Scholar] [CrossRef]
- World Health Organization WHO. Framework for Action on Interprofessional Education & Collaborative Practice. 1 September 2010. Available online: https://www.who.int/publications/i/item/framework-for-action-on-interprofessional-education-collaborative-practice (accessed on 21 December 2022).
- El-Awaisi, A.; El Hajj, M.S.; Joseph, S.; Diack, L. Perspectives of practising pharmacists towards interprofessional education and collaborative practice in Qatar. Int. J. Clin. Pharm. 2018, 40, 1388–1401. [Google Scholar] [CrossRef]
- Herath, C.; Zhou, Y.; Gan, Y.; Nakandawire, N.; Gong, Y.; Lu, Z. A comparative study of interprofessional education in global health care. Medicine 2017, 96, e7336. [Google Scholar] [CrossRef]
Category | Questions | Pillar 1 |
---|---|---|
General | What factors might you consider when deciding whether to partner with a US University/College of Pharmacy? | 1–5 |
Process | What challenges might exist in creating a formal agreement, such as a memorandum of understanding (MOU)? | 2–3 |
What would you expect to see in such an agreement? | 1–5 | |
Student Placement | How do you weigh the benefits or harms of student exchanges or placements at your institution? | 1–5 |
What preparation should students be aware of when traveling to a host country? | ||
Can you tell me about factors that impact the number/type/time of student placements? | ||
What factors are consistent from year to year and what factors are dependent upon the current context? | ||
What factors would influence the time of year that would be appropriate for students to travel? | ||
What supervision would be expected for students participating in international placements? From the host site? From the institutional site sending students? | ||
In what types of experiences would you consider involving students at your institution or partner institutions? | ||
What is expected of the US students while at the site and what contributions could they make? | ||
From your perspective, what hands-on roles do you feel are most appropriate for US-trained students | ||
What strategies have you seen that might allow for student involvement? | ||
What limitations or challenges exist that would limit international learners at your site? | ||
Student or Faculty/Staff Exchange | In thinking about mutually beneficial partnerships, what would be the value for your students or faculty/staff to receive? | 3 |
What might be some challenges that exist in developing bilateral exchanges for either students or faculty/staff? | 1–5 | |
Assessment | How do you evaluate exchange students on rotation? | 2, 5 |
What are your thoughts about completing evaluations for US students? | 3, 5 | |
What would make you more comfortable or less comfortable with evaluating US students? | 3, 5 | |
How would you define a successful collaboration between a US school of pharmacy and your institution? | 1–5 | |
What measures define a valuable experience for students? For the site? For others? | 1–5 |
Theme | Global Health Pillar |
---|---|
Personal connections are critical to partnership development and sustainability | Sustainability, Shared Leadership |
Understanding of each other’s programs and systems is essential for a successful collaborative partnership | Shared Leadership, Host-driven Education |
Mutual benefits can exist without bidirectional exchange and may be different for each partner | Mutually Beneficial Partnerships, Local Needs-Based Care, Host-Driven Education |
Key qualities for supporting overall collaboration and partnership include open-mindedness, adaptability, global citizenship, and cultural/structural awareness | Sustainability, Mutually Beneficial Partnerships, Host-Driven Education, Shared Leadership, and Local Needs-Based Care |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Prescott, G.M.; Jonkman, L.; Crutchley, R.D.; Dey, S.; Hong, L.T.; Malhotra, J.; Seo, S.-W.; Kawaguchi-Suzuki, M.; Truong, H.-A.; Unni, E.; et al. Characteristics of Successful International Pharmacy Partnerships. Pharmacy 2023, 11, 7. https://doi.org/10.3390/pharmacy11010007
Prescott GM, Jonkman L, Crutchley RD, Dey S, Hong LT, Malhotra J, Seo S-W, Kawaguchi-Suzuki M, Truong H-A, Unni E, et al. Characteristics of Successful International Pharmacy Partnerships. Pharmacy. 2023; 11(1):7. https://doi.org/10.3390/pharmacy11010007
Chicago/Turabian StylePrescott, Gina M., Lauren Jonkman, Rustin D. Crutchley, Surajit Dey, Lisa T. Hong, Jodie Malhotra, See-Won Seo, Marina Kawaguchi-Suzuki, Hoai-An Truong, Elizabeth Unni, and et al. 2023. "Characteristics of Successful International Pharmacy Partnerships" Pharmacy 11, no. 1: 7. https://doi.org/10.3390/pharmacy11010007
APA StylePrescott, G. M., Jonkman, L., Crutchley, R. D., Dey, S., Hong, L. T., Malhotra, J., Seo, S. -W., Kawaguchi-Suzuki, M., Truong, H. -A., Unni, E., Tsuchihashi, K., Forkan, N., & Abrons, J. P. (2023). Characteristics of Successful International Pharmacy Partnerships. Pharmacy, 11(1), 7. https://doi.org/10.3390/pharmacy11010007